|
DHDDS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.87810000054733E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.70959999999232E-05 |
| Normal-vs-Stage2 |
1.438650E-04 |
| Normal-vs-Stage3 |
5.171700E-02 |
| Normal-vs-Stage4 |
3.411500E-04 |
| Stage1-vs-Stage2 |
3.592400E-01 |
| Stage1-vs-Stage3 |
6.237800E-01 |
| Stage1-vs-Stage4 |
4.252100E-02 |
| Stage2-vs-Stage3 |
2.301600E-01 |
| Stage2-vs-Stage4 |
1.941390E-01 |
| Stage3-vs-Stage4 |
7.278100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.07959999618279E-08 |
| Normal-vs-AfricanAmerican |
9.258100E-02 |
| Normal-vs-Asian |
1.973600E-01 |
| Caucasian-vs-AfricanAmerican |
4.930600E-01 |
| Caucasian-vs-Asian |
7.148000E-01 |
| AfricanAmerican-vs-Asian |
6.727600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93840005052937E-09 |
| Normal-vs-Female |
1.694010E-01 |
| Male-vs-Female |
7.359800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.516200E-01 |
| Normal-vs-Extreme_Weight |
1.38650202430313E-11 |
| Normal-vs-Obese |
3.51600000000341E-05 |
| Normal-vs-Extreme_Obese |
2.314200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.858000E-01 |
| Normal_Weight-vs-Obese |
6.435000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.875800E-01 |
| Extreme_Weight-vs-Obese |
1.792350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.267400E-01 |
| Obese-vs-Extreme_Obese |
4.945000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.456000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.604650E-04 |
| Normal-vs-Age(61-80Yrs) |
1.81230000007027E-07 |
| Normal-vs-Age(81-100Yrs) |
2.150300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.492600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.186600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.345800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.701600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.090400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.863400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.34212649274923E-12 |
| Normal-VS-Type2 PRCC |
5.173800E-01 |
| Normal-VS-KIRP CIMP |
1.939820E-02 |
| Normal-VS-Unclassified PRCC |
5.385400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.784100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.470200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.612300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.332300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.346800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.305000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.166640E-01 |
| Normal-vs-N1 |
4.08560000000335E-05 |
| Normal-vs-N2 |
8.712300E-02 |
| N0-vs-N1 |
6.243900E-02 |
| N0-vs-N2 |
4.323400E-01 |
| N1-vs-N2 |
8.360600E-01 |
|
|
